Kenvue Inc. (NYSE:KVUE) Shares Acquired by Syon Capital LLC

Syon Capital LLC increased its position in Kenvue Inc. (NYSE:KVUE) by 78.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 29,276 shares of the company’s stock after buying an additional 12,865 shares during the quarter. Syon Capital LLC’s holdings in Kenvue were worth $630,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. UniSuper Management Pty Ltd purchased a new position in shares of Kenvue in the 3rd quarter worth $35,544,000. Stephens Inc. AR raised its position in Kenvue by 86.1% in the fourth quarter. Stephens Inc. AR now owns 57,694 shares of the company’s stock valued at $1,242,000 after purchasing an additional 26,700 shares during the period. Stifel Financial Corp raised its position in Kenvue by 60.4% in the fourth quarter. Stifel Financial Corp now owns 745,064 shares of the company’s stock valued at $16,041,000 after purchasing an additional 280,591 shares during the period. Fifth Third Bancorp raised its position in Kenvue by 35.3% in the fourth quarter. Fifth Third Bancorp now owns 277,580 shares of the company’s stock valued at $5,976,000 after purchasing an additional 72,435 shares during the period. Finally, The Manufacturers Life Insurance Company raised its position in Kenvue by 2.6% in the fourth quarter. The Manufacturers Life Insurance Company now owns 1,598,567 shares of the company’s stock valued at $34,417,000 after purchasing an additional 40,995 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have commented on KVUE. HSBC raised their price objective on Kenvue from $20.00 to $21.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. Sanford C. Bernstein assumed coverage on Kenvue in a research report on Thursday, April 11th. They issued an “underperform” rating and a $18.00 price objective on the stock. The Goldman Sachs Group assumed coverage on Kenvue in a research note on Friday, March 1st. They set a “neutral” rating and a $20.00 target price for the company. William Blair assumed coverage on Kenvue in a research note on Wednesday, April 3rd. They set a “market perform” rating for the company. Finally, Citigroup restated a “neutral” rating and set a $21.00 target price on shares of Kenvue in a research note on Tuesday, May 28th. One analyst has rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, Kenvue currently has an average rating of “Hold” and a consensus price target of $23.09.

Kenvue Stock Up 0.2 %

NYSE:KVUE traded up $0.04 during mid-day trading on Friday, reaching $18.07. The stock had a trading volume of 15,356,133 shares, compared to its average volume of 19,621,444. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.99 and a quick ratio of 0.68. The stock’s 50 day simple moving average is $19.39 and its two-hundred day simple moving average is $20.10. Kenvue Inc. has a 1-year low of $17.75 and a 1-year high of $26.74. The company has a market capitalization of $34.60 billion and a price-to-earnings ratio of 23.17.

Kenvue (NYSE:KVUE) last issued its earnings results on Tuesday, May 7th. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.03. Kenvue had a return on equity of 21.06% and a net margin of 9.63%. The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $3.79 billion. The firm’s revenue was down 24.9% on a year-over-year basis. Equities analysts anticipate that Kenvue Inc. will post 1.18 EPS for the current year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 22nd. Shareholders of record on Wednesday, May 8th were paid a $0.20 dividend. The ex-dividend date of this dividend was Tuesday, May 7th. This represents a $0.80 dividend on an annualized basis and a yield of 4.43%. Kenvue’s payout ratio is currently 102.56%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.